Analysis By Product and service (Reagents & Consumables, Instruments, and Software & Services), Technology (Molecular Assay Technologies and Non-Molecular Assay Technologies), and End User (Independent Reference Laboratories, Hospitals and Transplant Centers, and Others)
No. of Pages:145
Report Code:
BMIRE00025756
Category:
Life Sciences
Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market
The Middle East & Africa human leukocyte antigen (HLA) testing market is expected to grow from US$ 35.78 million in 2022 to US$ 52.59 million by 2028; it is estimated to grow at a CAGR of 6.6% from 2022 to 2028.
Despite the development of novel technological approaches such as optimized chemotherapy regimens, targeted therapies, and radiotherapy, patients suffering from many diseases still present poor survival outcomes. Technological advancements in histocompatibility have systematically addressed the issues related to the specificity of lymphocyte cross-matching. Treating a wide range of malignant and nonmalignant diseases requires hematopoietic stem cell transplantation (HSCT) as the last therapeutic resort. The HLA testing approach can help determine if the class I and II antibodies lead to a cross-match. The information obtained from the application of such sensitive and specific technologies can be used to predict cross-match results for highly sensitized patients.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa human leukocyte antigen (HLA) testing market growth at a notable CAGR during the forecast period.
Exhibit: Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Segmentation
The Middle East & Africa human leukocyte antigen (HLA) testing market is segmented into product & services, technology, end user, and country. Based on product & services, the market is segmented into reagents & consumables, instruments, and software & services. In terms of technology, the Middle East & Africa human leukocyte antigen (HLA) testing market is divided into molecular assay technologies and non-molecular assay technologies. The molecular assay technologies segment is sub segmented into PCR-based molecular assays, sequencing-based molecular assays, and others. Based on end user, the market is divided into independent reference laboratories, hospital and transplant centers, and others. Based on country, the Middle East & Africa human leukocyte antigen (HLA) testing market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa.
Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market — Companies Mentioned
THERMO FISHER SCIENTIFIC INC.; CareDx; QIAGEN; Illumina; Bio-Rad Laboratories, Inc.; F. HOFFMANN-LA ROCHE LTD.; and Takara Bio Inc. are among the major companies operating in the Middle East & Africa human leukocyte antigen (HLA) testing market.
Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Strategic Insights
Get more information on this report
Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Segmentation Analysis
Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Report Highlights
Middle East and Africa Human Leukocyte Antigen (HLA) Testing Report Scope
Report Attribute
Details
Market size in 2022
US$ 35.78 Million
Market Size by 2028
US$ 52.59 Million
CAGR (2022 - 2028)
6.6%
Historical Data
2020-2021
Forecast period
2023-2028
Segments Covered
By Product and service
Reagents & Consumables
Instruments
Software & Services
By Technology
Molecular Assay Technologies
Non-Molecular Assay Technologies
By End User
Independent Reference Laboratories
Hospitals and Transplant Centers
Regions and Countries Covered
Middle East and Africa
South Africa
Saudi Arabia
UAE
Rest of Middle East and Africa
Market leaders and key company profiles
THERMO FISHER SCIENTIFIC INC.
CareDx
QIAGEN
Illumina, Inc.
Bio-Rad Laboratories, Inc.
F. HOFFMANN-LA ROCHE LTD.
Takara Bio Inc.
Get more information on this report
Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Country and Regional Insights
Get more information on this report
Identical Market Reports with other Region/Countries
The List of Companies - Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market
THERMO FISHER SCIENTIFIC INC.
CareDx
QIAGEN
Illumina, Inc.
Bio-Rad Laboratories, Inc.
F. HOFFMANN-LA ROCHE LTD.
Takara Bio Inc.
Frequently Asked Questions
How big is the Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market?
The Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market is valued at US$ 35.78 Million in 2022, it is projected to reach US$ 52.59 Million by 2028.
What is the CAGR for Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market by (2022 - 2028)?
As per our report Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market, the market size is valued at US$ 35.78 Million in 2022, projecting it to reach US$ 52.59 Million by 2028. This translates to a CAGR of approximately 6.6% during the forecast period.
What segments are covered in this report?
The Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market report typically cover these key segments-
Product and service (Reagents & Consumables, Instruments, Software & Services)
End User (Independent Reference Laboratories, Hospitals and Transplant Centers)
What is the historic period, base year, and forecast period taken for Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market report:
Historic Period : 2020-2021
Base Year : 2022
Forecast Period : 2023-2028
Who are the major players in Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market?
The Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
THERMO FISHER SCIENTIFIC INC.
CareDx
QIAGEN
Illumina, Inc.
Bio-Rad Laboratories, Inc.
F. HOFFMANN-LA ROCHE LTD.
Takara Bio Inc.
Who should buy this report?
The Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market value chain can benefit from the information contained in a comprehensive market report.
Get Free Sample For Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market
